URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway
Authors:
Open Access
- 18 June 2020
- journal article
- research article
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 15 (1) , 1-12
Abstract
Background: Osteosarcoma is one of the most common malignant bone tumors with the annual global incidence of approximately four per million. Upregulated gene 4 (URG4) expression in the osteosarcoma tissue is closely associated with recurrence, metastasis, and poor prognosis of osteosarcoma. However, the biological function and underlying mechanisms of URG4 in osteosarcoma have not been elucidated. This study aimed to explore the expression and underlying mechanism of URG4 in osteosarcoma. Methods: The expression level of URG4 in osteosarcoma and normal tissues was compared using immunohistochemistry (IHC). PCR and western blotting (WB) techniques are used to detect URG4 mRNA and protein levels. Wound healing and Transwell analysis to assess the effect of URG4 on osteosarcoma cell migration and invasion. Cell Counting Kit-8 assay and colony proliferation assay were performed to evaluate the effects of silencing URG4 on the inhibition of cell proliferation. The cell cycle distribution was detected by flow cytometry, and a xenograft mouse model was used to verify the function of URG4 in vivo. Results: URG4 was found to be highly expressed in osteosarcoma tissues and cells, and its high expression was correlated with advanced Enneking stage, large tumor size, and tumor metastasis in osteosarcoma patients. The proliferation in osteosarcoma cell lines and cell cycle in the S phase was suppressed when siRNA was used to downregulate URG4. URG4 promoted cell proliferation and tumorigenesis in vitro and in vivo. WB verified that URG4 promotes cell proliferation in osteosarcoma via pGSK3β/β-catenin/cyclinD1 signaling. Conclusion: URG4, which is high-expressed in osteosarcoma, promotes cell cycle progression via GSK3β/β-catenin/cyclin D1 signaling pathway and may be a novel biomarker and potential target for the treatment of osteosarcoma.Keywords
Funding Information
- The National Natural Science Foundation of China (81760485)
This publication has 43 references indexed in Scilit:
- Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor ProgressionCells, 2014
- Wnt Pathway in Osteosarcoma, from Oncogenic to TherapeuticJournal of Cellular Biochemistry, 2014
- The -Catenin Destruction ComplexCold Spring Harbor Perspectives in Biology, 2012
- The expression of URGCP gene in prostate cancer cell lines: correlation with rapamycinMolecular Biology Reports, 2012
- Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3aPLOS ONE, 2012
- Wnt signaling from membrane to nucleus: β-catenin caught in a loopThe International Journal of Biochemistry & Cell Biology, 2012
- RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cellsGenetics and Molecular Research, 2010
- The expression of novel gene URG4 in osteosarcoma correlation with patients' prognosisPathology, 2009
- Enhanced Cell Survival of Gastric Cancer Cells By a Novel Gene URG4Neoplasia, 2006
- G1 cell-cycle control and cancerNature, 2004